Author

Shuofei Cheng

University of Freiburg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

Anne‐Marie Mes‐MassoniD· 1 shared Diane Michele ProvencheriD· 1 shared Eurídice Carmona· 1 shared Françis RodieriD· 1 shared Isabelle Clément· 1 shared Julie Lafontaine· 1 shared Kurosh RahimiiD· 1 shared Lise Portelance· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anne‐Marie Mes‐MassonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 30, 2023

A senescence-like state is beneficial for ovarian cancer treatment

Michael Skulimowski, Llilians Calvo, Shuofei Cheng…·Françis Rodier

This study shows that senescence in ovarian cancer cells after chemotherapy correlates with better patient survival, suggesting senescence could be a therapeutic target.

DOI 10.1101/2023.09.30.560300

humanbulk RNA-seq

𝕏 PostBluesky